ArticleOncotarget2015

New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.

Daniela Di Paolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.